Valor Intrínseco del S&P y Nasdaq Contáctenos
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Volver a todas las acciones

CalciMedica, Inc. CALC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$266.00
+41783.2%

Ha habido 50 transacciones internas recientes registradas para CalciMedica, Inc. (CALC), incluyendo 48 compras y 1 venta. El total de compras internas fue valorado en $2.43M y el total de ventas internas en $3.65K.

Internos destacados con actividad reciente incluyen Glicklich Alan, Roberts Eric W, Hebbar Sudarshan. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — CALC

Fecha Nombre Cargo Tipo de Transacción Acciones Precio Promedio Valor Acciones en Propiedad
2025-10-13 Glicklich Alan Director Concesión de RSU 937 $3.26 $3.05K 937
2025-09-18 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 2,500 $3.07 $7.68K 84,150
2025-09-15 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 3,400 $2.68 $9.1K 81,650
2025-09-12 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 5,000 $3.12 $15.6K 78,250
2025-09-09 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 2,343 $3.15 $7.38K 73,250
2025-08-29 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 800 $2.74 $2.19K 70,907
2025-08-28 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 9,200 $2.86 $26.34K 70,107
2025-08-21 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 3,508 $2.79 $9.8K 60,907
2025-08-20 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 2,000 $2.72 $5.44K 57,399
2025-08-19 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 1,000 $2.79 $2.79K 55,399
2025-08-19 Hebbar Sudarshan Chief Medical Officer Compra Informativa 9,563 $2.82 $26.96K 61,539
2025-08-15 Hebbar Sudarshan Chief Medical Officer Compra Informativa 4,392 $2.79 $12.27K 51,976
2025-08-15 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 5,076 $2.90 $14.71K 54,399
2025-08-14 Hebbar Sudarshan Chief Medical Officer Compra Informativa 1,584 $2.59 $4.09K 47,584
2025-07-28 Stauderman Kenneth A. Chief Scientific Officer Compra Informativa 1,000 $3.96 $3.96K 12,944
2025-07-25 Stauderman Kenneth A. Chief Scientific Officer Venta Informativa 1,000 $3.65 $3.65K -
2025-07-22 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 1,500 $3.78 $5.66K 49,323
2025-07-21 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Compra Informativa 1,000 $3.40 $3.4K 3,500
2025-07-21 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 1,500 $3.37 $5.06K 47,823
2025-07-18 Wilson Robert N Director Compra Informativa 4,500 $2.87 $12.92K 422,029
2025-07-18 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 2,000 $2.88 $5.76K 46,323
2025-07-14 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Compra Informativa 2,500 $2.47 $6.18K 2,500
2025-07-14 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 6,500 $2.43 $15.81K 44,323
2025-07-09 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 5,000 $1.60 $8.02K 37,823
2025-07-01 Stauderman Kenneth A. Chief Scientific Officer Compra Informativa 1,000 $1.85 $1.85K 1,000
2025-06-26 Bardin Stephen Chief Financial Officer Compra Informativa 2,000 $1.50 $3.01K 3,000
2025-06-26 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 4,500 $1.44 $6.48K 32,823
2025-06-24 Wilson Robert N Director Concesión de RSU 10,000 $1.65 $16.5K 10,000
2025-06-24 Middleton Fred A 10 Percent Owner Concesión de RSU 6,562 $1.53 $10.04K 6,562
2025-06-24 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Concesión de RSU 77,625 $1.53 $118.77K 77,625
2025-06-24 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Concesión de RSU 72,750 $1.53 $111.31K 72,750
2025-06-24 Shaw Allan Director Concesión de RSU 8,594 $1.53 $13.15K 8,594
2025-06-24 Glicklich Alan Director Concesión de RSU 4,166 $1.53 $6.37K 4,166
2025-06-24 Guerard Frederic Director Concesión de RSU 5,000 $1.53 $7.65K 5,000
2025-06-24 Bardin Stephen Chief Financial Officer Concesión de RSU 20,000 $1.53 $30.6K 20,000
2025-06-24 Dunn Michael J. President and COO Concesión de RSU 47,125 $1.53 $72.1K 47,125
2025-06-24 Hebbar Sudarshan Chief Medical Officer Concesión de RSU 83,300 $1.53 $127.45K 83,300
2025-06-24 Stauderman Kenneth A. Chief Scientific Officer Concesión de RSU 47,125 $1.53 $72.1K 47,125
2025-06-11 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 5,000 $1.85 $9.25K 28,323
2025-06-06 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 5,000 $1.78 $8.88K 23,323
2025-06-05 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Compra Informativa 5,100 $1.70 $8.67K 18,323
2025-05-30 Bardin Stephen Chief Financial Officer Compra Informativa 1,000 $1.69 $1.69K 41,000
2025-04-23 Leheny A. Rachel 10 Percent Owner, Officer: Chief Executive Officer Concesión de RSU 285,000 $1.53 $436.05K 285,000
2025-04-23 Roberts Eric W 10 Percent Owner, Officer: Chief Business Officer Concesión de RSU 160,000 $1.53 $244.8K 160,000
2025-04-23 Bardin Stephen Chief Financial Officer Concesión de RSU 130,000 $1.53 $198.9K 130,000
2025-04-23 Dunn Michael J. President and COO Concesión de RSU 125,000 $1.53 $191.25K 125,000
2025-04-23 Hebbar Sudarshan Chief Medical Officer Concesión de RSU 175,000 $1.53 $267.75K 175,000
2025-04-23 Stauderman Kenneth A. Chief Scientific Officer Concesión de RSU 125,000 $1.53 $191.25K 125,000
2025-01-15 Glicklich Alan Officer Desconocido - - - -
2025-01-15 Glicklich Alan Director Concesión de RSU 20,000 $3.02 $60.4K 20,000
■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento

Otros también ven

PDSB
PDSB
PDS Biotechnology Corporation
$1.36
+28.30%
 MAIA
MAIA
MAIA Biotechnology, Inc.
$1.42
+3.65%
 ELUT
ELUT
Elutia Inc.
$1.17
+2.63%
 XLO
XLO
Xilio Therapeutics, Inc.
$8.61
+0.23%
 LVTX
LVTX
LAVA Therapeutics N.V.
$1.74
-3.87%
 ATNM
ATNM
Actinium Pharmaceuticals, Inc.
$1.26
+14.55%
 RNXT
RNXT
RenovoRx, Inc.
$1.02
-0.97%
 TVRD
TVRD
Tvardi Therapeutics, Inc.
$3.47
+9.81%
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
📧 [email protected]
📞 +65 8912 8000
Envíanos un mensaje